SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-315556
Filing Date
2021-11-01
Accepted
2021-11-01 16:52:04
Documents
16
Period of Report
2021-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d244102d8k.htm   iXBRL 8-K 30093
2 EX-1.1 d244102dex11.htm EX-1.1 172675
3 EX-5.1 d244102dex51.htm EX-5.1 7010
4 EX-99.1 d244102dex991.htm EX-99.1 9250
5 EX-99.2 d244102dex992.htm EX-99.2 9244
  Complete submission text file 0001193125-21-315556.txt   416061

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rptx-20211027.xsd EX-101.SCH 2518
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20211027_lab.xml EX-101.LAB 19420
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20211027_pre.xml EX-101.PRE 12119
9 EXTRACTED XBRL INSTANCE DOCUMENT d244102d8k_htm.xml XML 3742
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 211367919
SIC: 2834 Pharmaceutical Preparations